Two studies investigated the role of CD8+ T cells on ridding AML caused by either mutation of nucleophosmin 1 (NPM1) or FMS-like tyrosine kinase receptor 3 internal tandem duplication (FLT3-ITD) [33,34]. The gene discussed is FLT3; the disease is acute myeloid leukemia.